Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis × Biological Products × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Carcinoma, Renal Cell 2 Triple Negative Breast Neoplasms 1 Refractory/Relapse Neuroblastoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Osteoporosis 1 Neuroendocrine Tumors 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, B-Cell 1 Kidney Neoplasms 1 Infertility 1 Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1 Hodgkin Disease 1 High Grade Cervical Intraepithelial Neoplasia 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Zoledronic Acid 14 Risedronic Acid 9 Vitamin D 7 Calcium 7 Letrozole 6 Absorptiometry, Photon 6 Cholecalciferol 5 Calcium Carbonate 5 Alendronate 5 Denosumab 4 Calcium Gluconate 3 parathyroid hormone-related peptide (1-36) 2 bicalutamide 2 Progesterone 2 Goserelin 2 Estradiol 2 Calcium Citrate 2 Aromatase Inhibitors 2 Anastrozole 2 xian ling gu bao 1 romosozumab 1 X-Rays 1 Toremifene 1 Testosterone 1 Technetium 1 Resistance Training 1 Raloxifene Hydrochloride 1 Radiotherapy 1 Parathyroid Hormone-Related Protein 1 Parathyroid Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01250314 2012-07-03

OSTEHOM

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Osteoporosis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡